Author/Authors :
Paul D. Stein، نويسنده , , Afzal Beemath، نويسنده , , Frederick A. Meyers، نويسنده , , Elias Skaf، نويسنده , , Ronald E. Olson، نويسنده ,
Abstract :
Background
As would be expected with a hypercoagulable state, pulmonary embolism (PE) occurs in sickle cell disease (SCD). Its frequency, however, is undetermined, largely because of difficulties in distinguishing it from thrombosis in situ. The prevalence of deep venous thrombosis (DVT) is also undetermined in patients with SCD. Knowing the prevalence of DVT would be an important step in the overall assessment of the risk of PE in these patients.
Methods
Data from the National Hospital Discharge Survey were assessed.
Results
In patients
Journal title :
The American Journal of Medicine
Journal title :
The American Journal of Medicine